Sonoma Pharmaceuticals, Inc.

SNOA Healthcare Drug Manufacturers Specialty & Generic

Sonoma Pharmaceuticals, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $19.5 million, up 36.7% from fiscal 2025. In the quarter to June 2026, revenue grew 59.6%, EPS grew 88.2% and free cash flow grew 69.3%, each against the same quarter a year earlier.

1.13 0.02 −1.74%
Market cap
$5.5M
P/E
0.0×
Fwd P/E
−2.0×
Dividend yield
—
F-score
3/9
Altman Z
−18.52
Beneish M
−1.69
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22 Mar '23 Mar '24 Mar '25 Mar '26
Cash and Short Term Investments
17.46 10.07 3.69 3.69 4.22 7.40 3.82 3.13 5.37 2.40
Receivables
2.11 1.54 3.48 3.97 2.81 2.41 2.57 2.90 2.23 2.53
Inventory
2.22 2.87 3.41 2.18 2.53 2.66 2.86 2.72 2.92 3.65
Total current assets
22.64 16.25 12.50 12.28 12.98 16.43 13.80 12.55 12.65 12.10
Property, Plant, Equpment (Net)
1.24 1.14 0.73 0.37 0.36 0.32 0.49 0.37 0.23 0.31
Long Term Assets (Tax, Deferred)
— — — — — 0.83 0.95 1.15 0.59 0.88
Long-term assets (Other)
0.08 0.49 0.12 0.77 0.11 0.08 0.07 0.07 0.07 0.06
Total non-current assets
2.82 2.95 1.95 2.28 2.00 2.42 2.43 2.19 1.05 1.86
Total Assets
25.46 19.21 14.45 14.56 14.99 18.85 16.23 14.74 13.69 13.96
Notes Payable
— — — — — — — 0.32 0.22 0.22
Accounts Payable
1.26 1.27 1.26 2.07 1.77 1.64 0.84 0.61 0.95 1.92
Accrued Expenses
1.30 1.41 1.50 1.77 1.15 1.84 2.03 2.11 2.22 2.25
Current Part of Debt
0.12 0.23 0.32 0.48 0.60 0.81 0.43 0.32 — —
Current Part of Capital Lease
0.07 0.15 0.14 — — — — — — —
Current Part of Taxes to Pay
0.01 — — — — — — — — —
Current Revenue (Deferred)
0.52 0.21 0.10 0.27 0.32 1.28 0.16 0.48 0.64 0.28
Other current liabilities
1.82 1.61 0.27 — — — — — — —
Total current liabilities
3.29 3.26 3.59 4.73 4.08 5.82 3.72 3.72 4.10 4.83
Long Term Debt (Total)
0.21 0.18 0.01 0.24 1.31 — — — — —
Non-current Revenue (Deferred)
0.53 0.44 0.36 0.25 0.23 0.18 0.14 0.09 0.02 —
Non-current Liabilities (Other)
0.00 0.00 — 3.73 3.48 3.84 4.24 4.71 5.14 5.56
Total non-current liabilities
0.74 0.62 0.37 4.21 5.55 4.33 4.54 4.88 5.19 6.03
Total liabilities
4.03 3.88 3.96 8.94 9.62 10.15 8.25 8.60 9.28 10.87
Additional Paid In Capital
168.71 176.74 184.07 186.56 189.22 197.37 200.90 203.21 206.59 207.32
Common Stock (Net)
0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 — —
Retained Earnings
(143.10) (157.44) (169.24) (175.33) (179.28) (184.36) (189.51) (194.35) (197.81) (200.98)
Common Equity (Total)
21.43 15.33 10.49 5.62 5.36 8.70 7.98 6.14 4.41 3.10
Shareholders Equity (Total)
21.43 15.33 10.49 5.62 5.36 8.70 7.98 6.14 4.41 3.10
Shareholders Equity and Liabilities (Total)
25.46 19.21 14.45 14.56 14.99 18.85 16.23 14.74 13.69 13.96
Shares (Common)
0.02 0.03 0.07 0.09 0.10 0.16 0.25 0.78 1.63 1.80
Shareholders Equity (Tangible)
21.43 15.33 10.49 5.62 5.36 8.70 7.98 6.14 4.41 3.10
Net Debt
(17.12) (9.66) (3.35) (2.97) (2.31) (6.59) (3.39) (2.80) (5.37) (2.40)
Total Debt
0.34 0.41 0.33 0.72 1.91 0.81 0.43 0.32 — —

Fold the line items

In millions of $ except per-share values · columns are period end dates